Literature DB >> 21710129

Early-onset SCA17 with 43 TBP repeats: expanding the phenotype?

L Tremolizzo1, N A Curtò, L Marzorati, F Lanzani, P Tarantino, G Annesi, C Ferrarese.   

Abstract

The SCA17 clinical phenotype includes characteristics associated with cerebellar and cortical atrophy such as ataxia, dementia, epilepsy, chorea and parkinsonian features. Here we describe the case of a 38-year-old male presenting with ataxia, cognitive impairment and seizures, who was found to carry 43 repeats on one allele of the TATA-binding protein (TBP) gene. Therefore, genetic analysis of TBP gene triplets was performed on the patient's entire family, identifying three asymptomatic carriers of the same allele. A neuroradiological phenotype appeared to segregate with this allele, suggesting that it may play at least a contributory role in the determination of SCA17.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710129     DOI: 10.1007/s10072-011-0662-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.

Authors:  K Nakamura; S Y Jeong; T Uchihara; M Anno; K Nagashima; T Nagashima; S Ikeda; S Tsuji; I Kanazawa
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

2.  Camptocormia associated with an expanded allele in the TATA box-binding protein gene.

Authors:  Josep Gamez; Alba Sierra-Marcos; Margarita Gratacós; Laurade Jorge; Nuria Raguer; Dulce Moncho-Rodriguez; Carlos Jacas; Juan Conejero; Merce Badia; Carlos Lorenzo-Bosquet; Victor Volpini; Joan Castell-Conesa
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

3.  Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA-binding protein (TBP) gene.

Authors:  Ashish Nanda; Sarah A Jackson; John D Schwankhaus; W Steven Metzer
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

4.  Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene.

Authors:  D Nolte; E Sobanski; A Wissen; J U Regula; C Lichy; U Müller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-28       Impact factor: 10.154

5.  Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.

Authors:  J-Y Kim; S Y Kim; J-M Kim; Y K Kim; K-Y Yoon; J Y Kim; B C Lee; J S Kim; S H Paek; S S Park; S E Kim; B S Jeon
Journal:  Neurology       Date:  2009-04-21       Impact factor: 9.910

6.  Intergenerational instability and marked anticipation in SCA-17.

Authors:  F Maltecca; A Filla; I Castaldo; G Coppola; N A Fragassi; M Carella; A Bruni; S Cocozza; G Casari; A Servadio; G De Michele
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

7.  Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease.

Authors:  Y R Wu; H Y Lin; C M Chen; K Gwinn-Hardy; L S Ro; Y C Wang; S H Li; J C Hwang; K Fang; H M Hsieh-Li; M L Li; L C Tung; M T Su; K T Lu; G J Lee-Chen
Journal:  Clin Genet       Date:  2004-03       Impact factor: 4.438

8.  Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.

Authors:  Masaya Oda; Hirofumi Maruyama; Osamu Komure; Hiroyuki Morino; Hideo Terasawa; Yuishin Izumi; Tohru Imamura; Minoru Yasuda; Keiji Ichikawa; Masafumi Ogawa; Masayasu Matsumoto; Hideshi Kawakami
Journal:  Arch Neurol       Date:  2004-02

9.  Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).

Authors:  Arndt Rolfs; Arnulf H Koeppen; Ingrid Bauer; Peter Bauer; Sven Buhlmann; Helge Topka; Ludger Schöls; Olaf Riess
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

10.  Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.

Authors:  Christine Zühlke; Andreas Dalski; Eberhard Schwinger; Ulrich Finckh
Journal:  BMC Med Genet       Date:  2005-07-01       Impact factor: 2.103

View more
  1 in total

1.  From normal gait to loss of ambulation in 6 months: a novel presentation of SCA17.

Authors:  R Mehanna; I Itin
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.